BMT Program at Northside Hospital — Atlanta, Georgia

BMT Program at Northside Hospital is a clinical research site located in Atlanta, Georgia, United States 30342.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

BMT Program at Northside Hospital has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma.

Sponsors: Medical College of Wisconsin, Bellicum Pharmaceuticals, National Heart, Lung, and Blood Institute (NHLBI).

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for BMT Program at Northside Hospital?

BMT Program at Northside Hospital has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has BMT Program at Northside Hospital conducted?

BMT Program at Northside Hospital has 7 clinical trials on record, with 1 currently active. Their work covers Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma.

Is BMT Program at Northside Hospital accredited by Crixeo Health?

BMT Program at Northside Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about BMT Program at Northside Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.